In this episode, listen to Guy A. Young, MD, as he counsels a teenage patient with severe hemophilia A and the patient’s mother on various available treatment options and strategies for optimizing hemophilia A prophylaxis and adherence. Topics include:

• Overcoming challenges to adherence
• Choice of standard vs extended half-life factor VIII vs emicizumab
• Safety and efficacy data with emicizumab

Presenter:

Guy A. Young, MD
Professor of Pediatrics
Director, Hemostasis and Thrombosis Center
Children’s Hospital Los Angeles
University of Southern California Keck School of Medicine
Los Angeles, California

Link to full program:
https://bit.ly/3FxrVk2

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.